Style | Citing Format |
---|---|
MLA | Rahmatidehkordi F, et al.. "Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 2, 2025, pp. 1081-1097. |
APA | Rahmatidehkordi F, Birang N, Jalalian MN, Tamtaji Z, Dadgostar E, Aschner M, Shafiee Ardestani M, Jafarpour H, Mirzaei H, Nabavizadeh F, Tamtaji OR (2025). Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(2), 1081-1097. |
Chicago | Rahmatidehkordi F, Birang N, Jalalian MN, Tamtaji Z, Dadgostar E, Aschner M, Shafiee Ardestani M, et al.. "Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 2 (2025): 1081-1097. |
Harvard | Rahmatidehkordi F et al. (2025) 'Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?', Naunyn-Schmiedeberg's Archives of Pharmacology, 398(2), pp. 1081-1097. |
Vancouver | Rahmatidehkordi F, Birang N, Jalalian MN, Tamtaji Z, Dadgostar E, Aschner M, et al.. Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(2):1081-1097. |
BibTex | @article{ author = {Rahmatidehkordi F and Birang N and Jalalian MN and Tamtaji Z and Dadgostar E and Aschner M and Shafiee Ardestani M and Jafarpour H and Mirzaei H and Nabavizadeh F and Tamtaji OR}, title = {Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?}, journal = {Naunyn-Schmiedeberg's Archives of Pharmacology}, volume = {398}, number = {2}, pages = {1081-1097}, year = {2025} } |
RIS | TY - JOUR AU - Rahmatidehkordi F AU - Birang N AU - Jalalian MN AU - Tamtaji Z AU - Dadgostar E AU - Aschner M AU - Shafiee Ardestani M AU - Jafarpour H AU - Mirzaei H AU - Nabavizadeh F AU - Tamtaji OR TI - Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms? JO - Naunyn-Schmiedeberg's Archives of Pharmacology VL - 398 IS - 2 SP - 1081 EP - 1097 PY - 2025 ER - |